Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers studied ...

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...

In systemic lupus erythematosus, chronic spontaneous urticaria did not raise SLEDAI scores, but cylindruria, mucosal ulcers, ...

Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic lupus erythematosus (SLE), providing further evidence that the emerging ...

Merck, a leading science and technology company, today announced positive data on enpatoran, an investigational, oral, novel TLR7/8 inhibitor, demonstrating clinically meaningful reduction in disease ...

Please provide your email address to receive an email when new articles are posted on . Among targeted small-molecule drugs, deucravacitinib had the best efficacy and safety in SLE. Dose and course of ...

In a new study, researchers have identified ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) as a novel biomarker that connects allergic rhinitis (AR, commonly known as hay fever), and ...

Please provide your email address to receive an email when new articles are posted on . Patients with SLE can experience pain and fatigue daily, which makes life difficult. Something people unfamiliar ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...